Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Hachulla

Showing results (131-140 of 506) with videos related to

Pageof 51
Sort By:
Scientific Reports|September 12, 2023
Intravenous immunoglobulins improve skin fibrosis in experimental models of systemic sclerosisSilvia Speca, Meryem-Maud Farhat, Manel Jendoubi, et al.
European Journal of Internal Medicine|May 11, 2021
Clinical significance of anti-Ro52 (TRIM21) antibodies in adult patients with connective tissue diseasesPaul Decker, Thomas Moulinet, Benjamin Lopez, et al.
JAMA Dermatology|May 26, 2018
Whole-Body Distribution and Clinical Association of Telangiectases in Systemic SclerosisMathieu Jouvray, David Launay, Sylvain Dubucquoi, et al.
International Journal of Cardiology|August 21, 2016
N-terminal pro-brain natriuretic peptide is a strong predictor of mortality in systemic sclerosisYannick Allanore, Andras Komocsi, Serena Vettori, et al.
Autoimmunity Reviews|August 26, 2014
Systemic sclerosis and prevalence of monoclonal immunoglobulinSalim Trad, Audrey Nosbaum, Lucile Musset, et al.
European Radiology|July 26, 2022
Dual-energy CT lung perfusion in systemic sclerosis: preliminary experience in 101 patientsAntoine Dupont, Vincent Koether, Julien Labreuche, et al.
Clinical and Experimental Rheumatology|June 30, 2023
Six medico-psycho-social dimensions of a pedagogical model used to define clusters of patients with Sjögren's syndrome and intentionality to participate in a patient education programmePascale Antoine, Sandrine Morell-Dubois, Hélène Maillard, et al.
The Journal of Rheumatology|March 17, 2020
Rituximab and Cyclophosphamide in Antisynthetase Syndrome-related Interstitial Lung Disease: An Observational Retrospective StudyVincent Langlois, André Gillibert, Yurdagül Uzunhan, et al.
Arthritis Research & Therapy|March 8, 2007
CTLA-4 +49A/G and CT60 gene polymorphisms in primary Sjögren syndromeJacques-Eric Gottenberg, Pascale Loiseau, Mariam Azarian, et al.
Clinical and Experimental Rheumatology|June 6, 2023
Relevance of inflammatory and complement activation biomarkers profiling in antiphospholipid syndrome patients outside acute thrombosisCecile M Yelnik, Marc Lambert, Elodie Drumez, et al.
Pageof 51

Showing results (131-140 of 506) with videos related to

Sort By:
Pageof 51
Scientific Reports|September 12, 2023
Intravenous immunoglobulins improve skin fibrosis in experimental models of systemic sclerosisSilvia Speca, Meryem-Maud Farhat, Manel Jendoubi, et al.
European Journal of Internal Medicine|May 11, 2021
Clinical significance of anti-Ro52 (TRIM21) antibodies in adult patients with connective tissue diseasesPaul Decker, Thomas Moulinet, Benjamin Lopez, et al.
JAMA Dermatology|May 26, 2018
Whole-Body Distribution and Clinical Association of Telangiectases in Systemic SclerosisMathieu Jouvray, David Launay, Sylvain Dubucquoi, et al.
International Journal of Cardiology|August 21, 2016
N-terminal pro-brain natriuretic peptide is a strong predictor of mortality in systemic sclerosisYannick Allanore, Andras Komocsi, Serena Vettori, et al.
Autoimmunity Reviews|August 26, 2014
Systemic sclerosis and prevalence of monoclonal immunoglobulinSalim Trad, Audrey Nosbaum, Lucile Musset, et al.
European Radiology|July 26, 2022
Dual-energy CT lung perfusion in systemic sclerosis: preliminary experience in 101 patientsAntoine Dupont, Vincent Koether, Julien Labreuche, et al.
Clinical and Experimental Rheumatology|June 30, 2023
Six medico-psycho-social dimensions of a pedagogical model used to define clusters of patients with Sjögren's syndrome and intentionality to participate in a patient education programmePascale Antoine, Sandrine Morell-Dubois, Hélène Maillard, et al.
The Journal of Rheumatology|March 17, 2020
Rituximab and Cyclophosphamide in Antisynthetase Syndrome-related Interstitial Lung Disease: An Observational Retrospective StudyVincent Langlois, André Gillibert, Yurdagül Uzunhan, et al.
Arthritis Research & Therapy|March 8, 2007
CTLA-4 +49A/G and CT60 gene polymorphisms in primary Sjögren syndromeJacques-Eric Gottenberg, Pascale Loiseau, Mariam Azarian, et al.
Clinical and Experimental Rheumatology|June 6, 2023
Relevance of inflammatory and complement activation biomarkers profiling in antiphospholipid syndrome patients outside acute thrombosisCecile M Yelnik, Marc Lambert, Elodie Drumez, et al.
Pageof 51